1. Lodge M, et al. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol. 83(2):110–122. 2007.
2. Goitein M, Jermann M. The relative costs of proton and X-ray radiation therapy. Clin Oncol (R Coll Radiol). 15(1):S37–50. 2003.
3. Peeters A, Grutters JP, et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol. 95(1):45–53. 2010.
4. SUZUKI K, et al. Quantitative analysis of beam delivery parameters and treatment process time for proton beam therapy. Med Phys. 38(7):4329–4337. 2011.
5. SUZUKI K, et al. Quantitative analysis of treatment process time and throughput capacity for spot scanning proton therapy. Med Phys. 43(7):3975–3986. 2016.
6. Chung K, Han Y, et al. The first private-hospital based pro ton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center. Radiat Oncol J. 33(4):337–343. 2015.
7. Nguyen PL, Zietman AL. High-dose external beam radiation for localized prostate cancer: current status and future challenges. Cancer J. 13:295–301. 2007.
8. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 294:1233–9. 2005.
9. Slater JD, Rossi Jr CJ, Yonemoto LT, et al. Proton therapy for prostate cancer: the Initial Loma Linda University experience. Int J Radiat Oncol Biol Phys. 59:348–52. 2004.
10. Bush DA, Slater JD, Shin BB, Cheek G, Miller DW, Slater JM. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest. 126:1198–203. 2004.
11. Hata M, Tokuuye K, Kagei K, et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys. 68:786–93. 2007.
12. Orecchia R, Zurlo A, Loasses A, et al. Particle beam therapy (hadrontherapy): basis for interest and clinical experience. Eur J Cancer. 34:459–68. 1998.
13. Laramore GE. Role of particle radiotherapy in the manage ment of head and neck cancer. Curr Opin Oncol. 21:224–31. 2009.
14. Jereczek-Fossa BA, Krengli M, Orecchia R. Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck. 28:750–60. 2006.
15. Hug EB, Sweeney RA, Nurre PM, Holloway KC, Slater JD, Munzenrider JE. Proton radiotherapy in management of pediatric base of skull tumors. Int J Radiat Oncol Biol Phys. 52:1017–24. 2002.
16. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 175:57–63. 1999.
17. Noël G, Habrand JL, Jauffret E, et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol. 179:241–8. 2003.
18. Van de Werf E, Verstraete J, Lievens Y. The cost of radiotherapy in a decade of technology evolution. Radiother Oncol. 102(1):148–53. 2012.
19. Van de Werf E, Lievens Y, et al. Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT. Radiother Oncol. 93(1):137–40. 2009.
20. Lievens Y, van den Bogaert W, Kesteloot K. Activity- based costing: a practical model for cost calculation in radiotherapy. Int J Radiat Oncol Biol Phys. 57(2):522–35. 2003.